Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Cerus Corporation

CERS•NASDAQ
Healthcare
Medical - Devices
$2.38
$-0.03(-1.24%)
U.S. Market opens in 16h 26m

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap457.2M
P/E Ratio-28.66
EPS (TTM)$-0.08
ROE-0.28%
Fundamental Analysis

AI Price Forecasts

1 Month$1.85
3 Months$2.58
1 Year Target$1.86

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.66 and a market capitalization of 457.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.24%
5-Day Change
0.42%
1-Month Change
-4.42%
3-Month Change
46.91%
6-Month Change
88.89%
Year-to-Date (YTD) Change
20.81%
1-Year Change
45.12%
3-Year Change
-17.07%
5-Year Change
-64.84%
All-Time (Max) Change
-80.37%

Contact Information

https://www.cerus.com
925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

6,140 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions